ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,600Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 315

$689K Total Retail Price of All Prescriptions

Rank: 33 out of 315

463 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 463 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

5% of this provider’s 463 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 8,905 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LISINOPRIL 431 396 1 3
SIMVASTATIN 384 355 2 1
PRAVASTATIN SODIUM 378 357 3 10
METOPROLOL SUCCINATE 361 334 4 13
METFORMIN HCL 342 305 5 7
AMLODIPINE BESYLATE 277 264 6 2
CHLORTHALIDONE 264 246 7 154
ATENOLOL 259 258 8 11
FUROSEMIDE 231 204 9 15
AMLODIPINE BESYLATE-BENAZEPRIL 216 174 10 26
TAMSULOSIN HCL 204 203 11 21
OMEPRAZOLE 198 177 12 9
ALLOPURINOL 188 170 13 14
LEVOTHYROXINE SODIUM 132 132 14 6
FINASTERIDE 128 122 15 60
WARFARIN SODIUM 124 91 16 20
DIGOXIN 122 99 17 45
LOSARTAN POTASSIUM 120 116 18 4
DONEPEZIL HCL 116 116 19 28
METOPROLOL TARTRATE 116 116 19 18
CARVEDILOL 113 104 21 22
ALENDRONATE SODIUM 111 105 22 12
GLIPIZIDE 98 79 23 30
POTASSIUM CHLORIDE 94 94 24 36
ATORVASTATIN CALCIUM 93 87 25 5
SERTRALINE HCL 84 69 26 100
MIRTAZAPINE 78 78 27 68
ESCITALOPRAM OXALATE 78 65 27 108
DIOVAN 77 72 29 27
NAMENDA 74 74 30 38
RANITIDINE HCL 70 70 31 42
IRBESARTAN 69 68 32 66
LANTUS SOLOSTAR 67 53 33 69
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 65 34 50
AVAPRO 59 59 35 138
ACETAMINOPHEN-CODEINE 59 58 S3 35 163
CLOPIDOGREL 59 58 35 25
FENTANYL 58 58 S2 38 160
PERMETHRIN 58 57 38 316
TRAZODONE HCL 58 44 38 93
NOVOLOG MIX 70-30 FLEXPEN 58 43 38 253
CELEBREX 57 57 42 34
HYDROCHLOROTHIAZIDE 57 52 42 16
LANTUS 57 57 42 113
SYMBICORT 57 53 42 135
SPIRIVA 55 55 46 74
ADVAIR DISKUS 54 48 47 46
PEN NEEDLE 53 53 48 91
PROAIR HFA 52 45 49 52
LOVASTATIN 50 50 50 8
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.